Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Spanagel, M. Shoaib (1994)
Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine.Neuroscience, 63 3
E. Joyce, S. Iversen (1979)
The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the ratNeuroscience Letters, 14
I. Maisonneuve, R. Keller, S. Glick (1991)
Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.European journal of pharmacology, 199 1
S. Glick, Carol Gallagher, L. Hough, K. Rossman, I. Maisonneuve (1992)
Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamineBrain Research, 588
M. Kunihara, Miwako Ohyama, Miyuki Nakano (1993)
Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.Japanese journal of pharmacology, 62 3
S. Cappendijk, M. Dzoljic (1993)
Inhibitory effects of ibogaine on cocaine self-administration in rats.European journal of pharmacology, 241 2-3
M. Narita, Tsutomu Suzuki, M. Misawa, H. Nagase (2005)
Antagonism of the morphine-induced Straub tail reaction by κ-opioid receptor activation in micePsychopharmacology, 110
R. Craft, L. Dykstra (1992)
Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.The Journal of pharmacology and experimental therapeutics, 260 1
I. Maisonneuve, R. Keller, S. Glick (1992)
Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in ratsBrain Research, 579
(1993)
Ibogaine alters cocaineinduced biogenic amine and psychostimulant dysfunction but not [3H]GBR-12935 binding to dopamine transporter protein
P. Ramarao, H. Jablonski, K. Rehder, H. Bhargava (1988)
Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats.European journal of pharmacology, 156 2
H. Sershen, A. Hashim, L. Hársing, A. Lajtha (1992)
Ibogaine antagonizes cocaine-induced locomotor stimulation in mice.Life sciences, 50 15
H. Sershen, L. Hársing, A. Hashim, A. Lajtha (1992)
Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.Life sciences, 51 13
F. Tulunay, A. Takemori (1974)
The increased efficacy of narcotic antagonists induced by various narcotic analgesics.The Journal of pharmacology and experimental therapeutics, 190 3
M. Babbini, W. Davis (1972)
Time‐dose relationships for locomotor activity effects of morphine after acute or repeated treatmentBritish Journal of Pharmacology, 46
M. Narita, T. Suzuki, M. Misawa, H. Nagase (1993)
Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice.Psychopharmacology, 110 1-2
(1991)
Interactions between ibogaine, a potential antiaddictive agent, and m o r
S. Pearl, K. Herrick-Davis, M. Teitler, S. Glick (1995)
Radioligand-binding study of noribogaine, a likely metabolite of ibogaineBrain Research, 675
(1971)
A comparative study of the toxicity of ibogaine and serotonin
D. Repke, D. Artis, J. Nelson, E. Wong (1994)
Abbreviated Ibogaine Congeners. Synthesis and Reactions of Tropan-3-yl-2- and -3-indoles. Investigation of an Unusual Isomerization of 2-Substituted Indoles Using Computational and Spectroscopic TechniquesJournal of Organic Chemistry, 59
G. Dichiara, A. Imperato (1988)
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.Proceedings of the National Academy of Sciences of the United States of America, 85 14
K. McGilliard, A. Takemori (1978)
Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.The Journal of pharmacology and experimental therapeutics, 207 3
M. Vasko, E. Domino (1978)
Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat.The Journal of pharmacology and experimental therapeutics, 207 3
A. Rattan, K. Koo, G. Tejwani, H. Bhargava (1992)
The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1–13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the ratBrain Research, 584
D. Devine, P. Leone, D. Pocock, R. Wise (1993)
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.The Journal of pharmacology and experimental therapeutics, 266 3
I. Maisonneuve, K. Rossman, R. Keller, S. Glick (1992)
Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in ratsBrain Research, 575
Carol Gallagher, Carol Gallagher, Lindsay Hough, Lindsay Hough, Sandra Keefner, Sandra Keefner, A. Seyed-Mozaffari, Sydney Archer, Stanley Click, Stanley Click (1995)
Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry.Biochemical pharmacology, 49 1
S. Glick, R. Shapiro, K. Drew, P. Hinds, J. Carlson (1986)
Differences in spontaneous and amphetamine-induced rotational behavior, and in sensitization to amphetamine, among Sprague-Dawley derived rats from different sourcesPhysiology & Behavior, 38
D. Deecher, M. Teitler, D. Soderlund, W. Bornmann, M. Kuehne, S. Glick (1992)
Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studiesBrain Research, 571
P. Zaratin, G. Clarke (1994)
Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats.European journal of pharmacology, 264 2
R. Yukhananov, Q. Zhai, S. Persson, C. Post, F. Nyberg (1993)
Chronic administration of morphine decreases level of dynorphin a in the rat nucleus accumbensNeuropharmacology, 32
M. Narita, Yuki Takahashi, Tsutomu Suzuki, M. Misawa, H. Nagase (2005)
An ATP-sensitive potassium channel blocker abolishes the potentiating effect of morphine on the bicuculline-induced convulsion in micePsychopharmacology, 110
R. Spanagel, M. Shoaib (1994)
Involvement of mesolimbic κ-opioid systems in the discriminative stimulus effects of morphineNeuroscience, 63
S. Glick, K. Rossman, S. Steindorf, I. Maisonneuve, J. Carlson (1991)
Effects and aftereffects of ibogaine on morphine self-administration in rats.European journal of pharmacology, 195 3
R. Spanagel, A. Herz, T. Shippenberg (1990)
The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis StudyJournal of Neurochemistry, 55
A. Young (2004)
Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxonePsychopharmacology, 88
213 121 121 4 4 S. M. Pearl S. D. Glick D. W. Johnson Department of Pharmacology and Neuroscience Albany Medical college 12208 Albany NY USA Department of Physiology University of New England. College of Osteopathic Medicine 04005 Biddefore ME USA Abstract Ibogaine is currently being investigated for its potential use as an anti-addictive agent. In the present study we sought to determine whether prior morphine exposure influences the ability of ibogaine to inhibit morphine-induced locomotor stimulation. Female Sprague-Dawley rats were pretreated once a day for 1–4 days with morphine (5, 10, 20 or 30 mg/kg, IP) or saline and then received ibogaine (40 mg/kg, IP) 5 h after the last morphine pretreatment dose. Compared to rats pretreated with saline, rats pretreated with morphine (10, 20 or 30 mg/kg, IP) before ibogaine (40 mg/kg, IP) showed a significant reduction in morphine-induced (5 mg/kg, IP) locomotor stimulation when tested 19 h after ibogaine administration. Furthermore, this effect was apparent over a range of ibogaine (5–60 mg/kg, IP) and morphine test (2.5–5 mg/kg, IP) dosages. Doses of ibogaine (5 and 10 mg/kg, IP) which alone were inactive inhibited morphine-induced locomotor activity when rats had been pretreated with morphine. These results, showing that morphine pre-exposure affects ibogaine activity, suggest that variable histories of opioid exposure might account for individual differences in the efficacy of ibogaine to inhibit opioid addiction.
Psychopharmacology – Springer Journals
Published: Oct 1, 1995
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.